Alexiades-Arme Macrene MD is categorized under Dermatologists in New York City, NY and active since 2005.
Alexiades-Arme Macrene MD was established in 2005, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Dermatologists business, which does work in the B2C market, and is classified as a Dermatologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Macrene Alexiades-Arme at the company’s single location by writing to 955 Park Avenue, New York City, New York NY 10028 or by phoning (212) 570-6800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Alexiades-Arme Macrene MD |
Contact Person: | Macrene Alexiades-Arme |
Address: | 955 Park Avenue, New York City, New York 10028 |
Phone Number: | (212) 570-6800 |
Website Address: | drmacrene.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2005 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Dermatologists |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Alexiades-Arme Macrene MD was started in 2005 to provide professional Dermatologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Macrene Alexiades-Arme for inquiries that concern Alexiades-Arme Macrene MD by calling the company number (212) 570-6800, as your correspondence is most welcome. Additionally, the physical location of the single location of Alexiades-Arme Macrene MD can be found at the coordinates 40.777429,-73.959127 as well as the street address 955 Park Avenue in New York City, New York 10028.
For its online presence, you may visit Alexiades-Arme Macrene MD’s website at drmacrene.com and engage with its social media outlets through on Twitter and on Facebook.